H+H International A/S (CPH: HH)
Denmark
· Delayed Price · Currency is DKK 74.60
-0.20 (-0.27%)
Dec 20, 2024, 4:59 PM CET
H+H International Revenue
H+H International had revenue of 729.00M DKK in the quarter ending September 30, 2024, with 4.29% growth. This brings the company's revenue in the last twelve months to 2.70B, down -6.32% year-over-year. In the year 2023, H+H International had annual revenue of 2.67B, down -25.86%.
Revenue (ttm)
2.70B
Revenue Growth
-6.32%
P/S Ratio
0.45
Revenue / Employee
2.25M
Employees
1,261
Market Cap
1.22B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 2.67B | -932.00M | -25.86% |
| Dec 31, 2022 | 3.60B | 584.00M | 19.34% |
| Dec 31, 2021 | 3.02B | 366.00M | 13.79% |
| Dec 31, 2020 | 2.65B | -186.00M | -6.55% |
| Dec 31, 2019 | 2.84B | 317.00M | 12.56% |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
| Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Novozymes A/S | 22.71B |
| SP Group A/S | 2.85B |
| Flügger group A/S | 2.25B |
| RIAS A/S | 319.09M |
| Scandinavian Investment Group A/S | 28.00M |
| Hove A/S | 176.31M |
| Novo Nordisk A/S | 270.58B |
| DSV A/S | 160.12B |